Results 251 to 260 of about 102,686 (380)

Elevated neurofilament light levels in acute anorexia nervosa are associated with alterations in white matter volume and connectivity networks

open access: yesJournal of Child Psychology and Psychiatry, EarlyView.
Background Anorexia nervosa (AN) is a severe eating disorder associated with drastic reductions in gray and white matter (WM) volume and structural connectivity alterations. However, the hypotheses regarding underlying mechanisms are inconclusive. The current study investigated the relationships of WM volume as well as WM network architecture with ...
Inger Hellerhoff   +10 more
wiley   +1 more source

Characterisation of microstructural alterations in a weight drop mTBI rat model : a longitudinal diffusion MRI and histological analysis [PDF]

open access: yes, 2018
Braeckman, Kim   +4 more
core  

Combinatorial targeting of MYC/BCL2‐associated vulnerabilities in high‐grade B‐cell lymphoma

open access: yes
British Journal of Haematology, EarlyView.
Giulio Donati   +6 more
wiley   +1 more source

Evaluation of the effectiveness and safety of ONO‐2910 for the treatment of diabetic polyneuropathy: An early Phase IIa, multicenter, randomized, placebo‐controlled, double‐blind study in Japanese patients

open access: yesJournal of Diabetes Investigation, EarlyView.
ABSTRACT Aims/Introduction Diabetic polyneuropathy (DPN) is common in patients with diabetes. Its symptoms include pain, numbness, and impaired neurosensory function. ONO‐2910 promotes Schwann cell differentiation and is being developed for DPN. Materials and Methods This Phase IIa randomized controlled trial evaluated the effectiveness and safety of ...
Yukiko Onishi   +8 more
wiley   +1 more source

The “Reducing Inflammation for Greater Health Trial (RIGHT)” Study—Concept, Rationale, and Design

open access: yesJournal of the American Geriatrics Society, EarlyView.
ABSTRACT The Reducing Inflammation for Greater Health Trial's (RIGHT) study is a single‐center, randomized, double‐blind, placebo‐controlled trial designed to test whether clazkizumab, an interleukin‐6 (IL‐6) inhibitor, can improve or slow decline in physical, cognitive, and vascular function in older adults, when compared to a placebo.
Sebastian E. Sattui   +11 more
wiley   +1 more source

Comparative analysis of cerebrospinal fluid neurofilament medium, light and heavy chain in neurodegenerative diseases using an in-house assay for the detection of neurofilament medium chain. [PDF]

open access: yesEBioMedicine
Fazeli B   +15 more
europepmc   +1 more source

Studies on the biosynthesis of neurofilament proteins. [PDF]

open access: bronze, 1980
Henryk Czosnek   +2 more
openalex   +1 more source

Home - About - Disclaimer - Privacy